These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9757793)
41. Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents. Pau AK; Slone RB Lippincotts Prim Care Pract; 1999; 3(1):39-54. PubMed ID: 10214201 [No Abstract] [Full Text] [Related]
43. FDA approves first drug in new class of antibiotics. Senior K Lancet; 2000 Apr; 355(9214):1523. PubMed ID: 10801180 [No Abstract] [Full Text] [Related]
44. The fluoroquinolones: new antibiotics in ophthalmology. Ogawa GS; Hyndiuk RA Int Ophthalmol Clin; 1993; 33(4):59-68. PubMed ID: 8258498 [No Abstract] [Full Text] [Related]
45. [Comparative characteristics of respiratory fluoroquinolones registered in Russia]. Ushakalova EA Antibiot Khimioter; 2002; 47(11):38-45. PubMed ID: 12698579 [No Abstract] [Full Text] [Related]
46. Tracking antibiotics up the food chain. Byrd DM; Cox LA; Wilson JD Science; 2001 Mar; 291(5513):2550. PubMed ID: 11286272 [No Abstract] [Full Text] [Related]
47. [The use of fluoroquinolone plasma levels by physicians]. Pulcini C; Bernard E; Garraffo R; Roger PM; Tempesta S; Dellamonica P Presse Med; 2004 Dec; 33(21):1502-4. PubMed ID: 15614171 [TBL] [Abstract][Full Text] [Related]
48. Pharmacodynamics not likely to appear in antimicrobial labeling soon. Thompson CA Am J Health Syst Pharm; 2006 Nov; 63(22):2168-72. PubMed ID: 17090729 [No Abstract] [Full Text] [Related]
49. NDA filed for nitazoxanide. AIDS Patient Care STDS; 1998 May; 12(5):409-10. PubMed ID: 11361985 [No Abstract] [Full Text] [Related]
50. [Fluoroquinolones]. Damas P Rev Med Liege; 1996 Jan; 51(1):50-2. PubMed ID: 8701137 [No Abstract] [Full Text] [Related]
51. Thalidomide recommended for approval under tight restrictions. Miller JL Am J Health Syst Pharm; 1997 Oct; 54(20):2270-1, 2277-8. PubMed ID: 9347101 [No Abstract] [Full Text] [Related]
52. The fluroquinolones. Fitzgerald M J Am Acad Nurse Pract; 1994 Sep; 6(9):447-9. PubMed ID: 7946647 [No Abstract] [Full Text] [Related]
53. Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression. Slavin MA; Worth LJ; Seymour JF; Thursky KA J Clin Oncol; 2019 May; 37(13):1139-1140. PubMed ID: 30844318 [No Abstract] [Full Text] [Related]
54. 21st International Congress of Chemotherapy. Birmingham, United Kingdom, 4-7 July 1999. Abstracts. J Antimicrob Chemother; 1999 Jul; 44 Suppl A():3-184. PubMed ID: 10488381 [No Abstract] [Full Text] [Related]
55. Fluoroquinolone use in children. Sabharwal V; Marchant CD Pediatr Infect Dis J; 2006 Mar; 25(3):257-8. PubMed ID: 16511391 [No Abstract] [Full Text] [Related]
56. Common questions about the newer fluoroquinolone antibiotics. North DS Nurse Pract; 1999 Mar; 24(3):124-7. PubMed ID: 10100244 [No Abstract] [Full Text] [Related]
57. Use of fluoroquinolones: practical considerations. Ponte CD; Fisher MA Am Fam Physician; 1993 Apr; 47(5):1243-9. PubMed ID: 8465719 [TBL] [Abstract][Full Text] [Related]
58. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571 [TBL] [Abstract][Full Text] [Related]